Ortivus AB ser. B
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more
Market Cap & Net Worth: Ortivus AB ser. B (ORTI-B)
Ortivus AB ser. B (ST:ORTI-B) has a market capitalization of $11.32 Million (Skr126.95 Million) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #32865 globally and #512 in its home market, demonstrating a -2.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ortivus AB ser. B's stock price Skr1.46 by its total outstanding shares 86952254 (86.95 Million).
Ortivus AB ser. B Market Cap History: 2015 to 2026
Ortivus AB ser. B's market capitalization history from 2015 to 2026. Data shows change from $27.44 Million to $11.32 Million (-9.48% CAGR).
Index Memberships
Ortivus AB ser. B is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$4.71 Billion | 0.07% | #160 of 281 |
Weight: Ortivus AB ser. B's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ortivus AB ser. B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ortivus AB ser. B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.13x
Ortivus AB ser. B's market cap is 0.13 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $21.70 Million | $74.28 Million | -$7.08 Million | 0.29x | N/A |
| 2017 | $14.34 Million | $58.80 Million | -$11.61 Million | 0.24x | N/A |
| 2018 | $12.25 Million | $52.20 Million | -$13.39 Million | 0.23x | N/A |
| 2019 | $29.14 Million | $50.85 Million | -$16.01 Million | 0.57x | N/A |
| 2020 | $39.92 Million | $107.58 Million | $11.33 Million | 0.37x | 3.52x |
| 2021 | $40.62 Million | $94.27 Million | $9.21 Million | 0.43x | 4.41x |
| 2022 | $42.79 Million | $104.51 Million | $5.89 Million | 0.41x | 7.26x |
| 2023 | $28.76 Million | $84.08 Million | -$18.25 Million | 0.34x | N/A |
| 2024 | $10.77 Million | $80.41 Million | -$24.90 Million | 0.13x | N/A |
| 2025 | $9.42 Million | $73.40 Million | -$21.88 Million | 0.13x | N/A |
Competitor Companies of ORTI-B by Market Capitalization
Companies near Ortivus AB ser. B in the global market cap rankings as of March 19, 2026.
Key companies related to Ortivus AB ser. B by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Ortivus AB ser. B Historical Marketcap From 2015 to 2026
Between 2015 and today, Ortivus AB ser. B's market cap moved from $27.44 Million to $ 11.32 Million, with a yearly change of -9.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr11.32 Million | +20.16% |
| 2025 | Skr9.42 Million | -12.59% |
| 2024 | Skr10.77 Million | -62.53% |
| 2023 | Skr28.76 Million | -32.79% |
| 2022 | Skr42.79 Million | +5.34% |
| 2021 | Skr40.62 Million | +1.75% |
| 2020 | Skr39.92 Million | +36.97% |
| 2019 | Skr29.14 Million | +137.97% |
| 2018 | Skr12.25 Million | -14.59% |
| 2017 | Skr14.34 Million | -33.93% |
| 2016 | Skr21.70 Million | -20.90% |
| 2015 | Skr27.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Ortivus AB ser. B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.32 Million USD |
| MoneyControl | $11.32 Million USD |
| MarketWatch | $11.32 Million USD |
| marketcap.company | $11.32 Million USD |
| Reuters | $11.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.